Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.9% – Should You Sell?

Shares of Anbio Biotechnology (NASDAQ:NNNN) traded down 5.9% during mid-day trading on Monday . The stock traded as low as $7.40 and last traded at $7.2150. 5,122 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 59,382 shares. The stock had previously closed at $7.67.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Anbio Biotechnology currently has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The firm has a 50-day simple moving average of $10.51 and a 200-day simple moving average of $20.02.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.